Lucid Diagnostics Inc. (NASDAQ: LUCD)
$0.89
+0.0123 ( +1.41% ) 24.3K
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
Market Data
Open
$0.89
Previous close
$0.87
Volume
24.3K
Market cap
$45.86M
Day range
$0.85 - $0.89
52 week range
$0.63 - $1.72
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-q | Quarterly Reports | 77 | Nov 13, 2023 |
| 8-k | 8K-related | 12 | Nov 13, 2023 |
| 8-k | 8K-related | 14 | Oct 18, 2023 |
| 4 | Insider transactions | 1 | Sep 27, 2023 |
| 4/a | Other | 1 | Sep 27, 2023 |
| 4 | Insider transactions | 1 | Sep 22, 2023 |
| 10-q | Quarterly Reports | 76 | Aug 14, 2023 |